Woodrow Adam 4
4 · Paratek Pharmaceuticals, Inc. · Filed Dec 14, 2022
Insider Transaction Report
Form 4
Woodrow Adam
VP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2022-12-13$1.96/sh−6,253$12,256→ 635,534 total - Sale
Common Stock
2022-12-12$1.98/sh−3,820$7,564→ 641,787 total
Footnotes (3)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit awards, pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.96 to $2.00. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.93 to $2.01. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4.